Tibial nerve decompression for the prevention of the diabetic foot: a cost–utility analysis using Markov model simulations
Open Access
Abstract
Objective To determine whether tibial neurolysis performed as a surgical intervention for patients with diabetic neuropathy and superimposed tibial nerve compression in the prevention of the diabetic foot is cost-effective when compared with the current prevention programme. Design A baseline analysis was built on a 5-year model to determine the cumulative incidence of foot ulcers and amputations with each strategy. Subsequently, a cost-effectiveness analysis and cohort-level Markov simulations were conducted with a model composed of 20 6-month cycles. A sensitivity analysis was also performed. Setting A Markov model was used to simulate the effects of standard prevention compared with tibial neurolysis on the long-term costs associated with foot ulcers and amputations. This model included eight health states. Participants Each cohort includes simulated patients with diabetic neuropathy at different levels of risk of developing foot ulcers and amputations. Primary and secondary outcome measures The primary outcome was the long-term trends concerning the development of ulcers and amputations with each strategy. The secondary outcome measures were quality adjusted life years (QALYs), incremental cost-effectiveness and net monetary benefits of the optimal strategy. Results When compared with standard prevention, for a patient population of 10 000, surgery prevented a simulated total of 1447 ulcers and 409 amputations over a period of 5 years. In a subsequent analysis that consisted of 20 6-month cycles (10 years), the incremental cost of tibial neurolysis compared with current prevention was $12 772.28; the incremental effectiveness was 0.41 QALYs and the incremental cost-effectiveness ratio was $31 330.78. Survival was 73% for those receiving medical prevention compared with 95% for those undergoing surgery. Conclusion These results suggest that among patients with diabetic neuropathy and superimposed nerve compression, surgery is more effective at preventing serious comorbidities and is associated with a higher survival over time. It also generated greater long-term economic benefits.Keywords
This publication has 20 references indexed in Scilit:
- The Positive Effect of Neurolysis on Diabetic Patients with Compressed Nerves of the Lower ExtremitiesPlastic and Reconstructive Surgery - Global Open, 2013
- Prevention of Ulceration, Amputation, and Reduction of Hospitalization: Outcomes of a Prospective Multicenter Trial of Tibial Neurolysis in Patients with Diabetic NeuropathyJournal of Reconstructive Microsurgery, 2012
- Legislating against Use of Cost-Effectiveness InformationNew England Journal of Medicine, 2010
- What does one minute of operating room time cost?Journal of Clinical Anesthesia, 2010
- The Four Medial Ankle Tunnels: A Critical Review of Perceptions of Tarsal Tunnel Syndrome and NeuropathyNeurosurgery Clinics of North America, 2008
- Health-Economic Consequences of Diabetic Foot LesionsClinical Infectious Diseases, 2004
- Medical Treatment of Diabetic Foot InfectionsClinical Infectious Diseases, 2004
- Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulationsDiabetologia, 2001
- Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group.Diabetes Care, 1999
- Surgery for limb threatening ischaemia: A reappraisal of the costs and benefitsEuropean Journal of Vascular and Endovascular Surgery, 1995